SCHEMBL25205398

SCHEMBL25205398

O=C(Nc1ccc(Cl)c(Cl)c1)N1CCc2nonc2C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
GPR142 Q7Z601 4/20 0.54
TRPV1 Q8NER1 2/20 0.54
LMNA P02545 4/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
MAPT P10636 4/20 0.52
HTT P42858 3/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP2D6 P10635 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C19 P33261 1/20 0.48
EPHX2 P34913 2/20 0.47
EPHX1 P07099 1/20 0.47
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25234105 0.84 GPR142 (0.58) MEN1KMT2ANPC1RAB9AGPR142
SCHEMBL25238835 0.83 GPR142 (0.58) MEN1KMT2ANPC1RAB9AGPR142
SCHEMBL25240416 0.78 GPR142 (0.60) MEN1KMT2ANPC1RAB9AGPR142
SCHEMBL25231026 0.78 GPR142 (0.60) MEN1KMT2ANPC1RAB9AGPR142
SCHEMBL25574408 0.77 GPR142 (0.59) MEN1KMT2ANPC1RAB9AGPR142
SCHEMBL25255425 0.77 GPR142 (0.59) MEN1KMT2ANPC1RAB9AGPR142
SCHEMBL30377407 0.77 GPR142 (0.59) MEN1KMT2ANPC1RAB9AGPR142
SCHEMBL25574406 0.77 GPR142 (0.59) MEN1KMT2ANPC1RAB9AGPR142
SCHEMBL25257595 0.77 GPR142 (0.61) MEN1KMT2ANPC1RAB9AGPR142
SCHEMBL27979643 0.77 MEN1 (0.84) MEN1KMT2ANPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174530-A1 N-(PHENYLAMINOCARBONYL) TETRAHYDRO-ISOQUINOLINES AND RELATED COMPOUNDS AS MODULATORS OF GPR65 Pathios Therapeutics Limited (GB) 2023-06-08 US disclosed
US-20230174530-A1 N-(PHENYLAMINOCARBONYL) TETRAHYDRO-ISOQUINOLINES AND RELATED COMPOUNDS AS MODULATORS OF GPR65 Pathios Therapeutics Limited (GB) 2023-06-08 US disclosed
US-20230174530-A1 N-(PHENYLAMINOCARBONYL) TETRAHYDRO-ISOQUINOLINES AND RELATED COMPOUNDS AS MODULATORS OF GPR65 Pathios Therapeutics Limited (GB) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174530-A1 N-(PHENYLAMINOCARBONYL) TETRAHYDRO-ISOQUINOLINES AND RELATED COMPOUNDS AS MODULATORS OF GPR65 GPR3, GPR65, GPR52 MEN1 4615/4885KMT2A 2819/4885NPC1 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.